1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline
Aging Cell · 2025
DOI: 10.1111/acel.70261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Hao Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics - Advanced Biomedical Imaging Facility, Huazhong Universit…. Hauptthemen laut MEDLINE: Low-Level Light Therapy, Brain, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation of China, Natural Science Foundation of Wuhan.
Abstract (Originalsprache)
Aging imposes a significant socioeconomic and healthcare burden worldwide, while effective therapy is still lacking. Impaired brain drainage and excessive accumulation of metabolites and toxins such as advanced glycation end products (AGEs) are characteristics of aging that contribute to the development of neurological disorders. Recent discoveries have highlighted the role of meningeal lymphatic vessels (MLVs) in the clearance of toxic metabolites, cells, tumors, and viruses from the brain, positioning them as significant targets for the treatment of various brain diseases. In this study, we demonstrate that noninvasive 1275‐nm photobiomodulation (PBM) effectively improves brain drainage and promotes lymphatic clearance of AGEs in a D‐galactose‐induced aging model (AM) in male mice, while being safe due to its minimal thermal effects. These improvements are associated with nitric oxide release‐mediated dilation of MLVs. PBM can also effectively ameliorate redox imbalance, neuroinflammation, and neuronal damage, as well as improve spatial learning ability and short‐term recognition memory in AM mice. These findings introduce a promising and easily accessible strategy for nonpharmacological phototherapy of meningeal brain drainage and neurological decline in individuals with aging and aging‐related neurodegenerative diseases, offering high potential for rapid implementation into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics - Advanced Biomedical Imaging Facility, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Saratov State University, Saratov, Russia.
- School of Optical Electronic Information, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Dongyu Li, Tingting Yu
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation of China
- Natural Science Foundation of Wuhan
- Interdisciplinary Research Program of HUST
- The innovation fund of WNLO
- Russian Science Foundation
Zitieren
APA
Lin, H., Liu, S., Yang, Q., Li, J., Wang, J., Semyachkina-Glushkovskaya, O., Li, D., Yu, T., & Zhu, D. (2025). 1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline. Aging Cell. https://doi.org/10.1111/acel.70261
Vancouver
Lin H, Liu S, Yang Q, Li J, Wang J, Semyachkina-Glushkovskaya O, et al. 1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline. Aging Cell. 2025. doi:10.1111/acel.70261
BibTeX
@article{Lin2025,
author = {Lin, Hao and Liu, Shaojun and Yang, Qihang and Li, Junming and Wang, Jue and Semyachkina-Glushkovskaya, Oxana and Li, Dongyu and Yu, Tingting and Zhu, Dan},
title = {1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70261}
}
EUVIMED